Holen Sie sich die Stockscreener-App
701.83
0.40%
2.77
Vorhandelsmarkt:
702.50
0.67
+0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$699.06
Offen:
$702.19
24-Stunden-Volumen:
529.32K
Relative Volume:
1.04
Marktkapitalisierung:
$56.04B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
55.64
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
-3.32%
1M Leistung:
-1.09%
6M Leistung:
+33.45%
1J Leistung:
+57.81%
1-Tages-Spanne:
$693.72
$707.46
1-Wochen-Bereich:
$693.72
$732.03
52-Wochen-Spanne:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Resistance Check: Will IDEXX Laboratories Inc stock deliver consistent dividendsWeekly Risk Summary & Advanced Technical Signal Analysis - BỘ NỘI VỤ
Barclays Initiates Coverage of IDEXX Laboratories (IDXX) with Overweight Recommendation - Nasdaq
Barclays Initiates Coverage on IDEXX Laboratories (IDXX) with Ov - GuruFocus
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $850 - 富途牛牛
iSAM Funds UK Ltd Takes $1.85 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target - marketscreener.com
Ossiam Grows Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Purchased by California Public Employees Retirement System - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
How is IDEXX Laboratories’ stock performance compared to other health care stocks? - MSN
Mirabella Financial Services LLP Sells 4,783 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Guggenheim Capital LLC Purchases 3,577 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
First Trust Advisors LP Purchases 35,526 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Edgestream Partners L.P. Has $1.48 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Brown Advisory Inc. Sells 10,408 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Amundi Has $366.69 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
At US$717, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - Yahoo Finance
Can IDEXX Laboratories Inc. stock continue upward trendEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Epoch Investment Partners Inc. Has $134.40 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Can IDEXX Laboratories Inc. (IX1) stock stage a strong rebound this quarterPortfolio Performance Summary & Real-Time Sentiment Analysis - Newser
IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge? - The Globe and Mail
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Invesco Ltd. Has $621.34 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Can IDEXX Laboratories Inc. stock resist sector downturns2025 Top Decliners & Verified Stock Trade Ideas - Newser
Should I hold or sell IDEXX Laboratories Inc. stock in 2025Portfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser
Arrowstreet Capital Limited Partnership Acquires 15,227 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks? - Barchart.com
Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Norges Bank Invests $221.96 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Granite Investment Partners LLC Has $2.06 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
D L Carlson Investment Group Inc. Buys New Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Is IDEXX Laboratories Inc. (IX1) stock worth buying before Fed action2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Veterinary Software Market Set to Witness Significant Growth by 2025-2032 | Idexx Laboratories, Covetrus Inc., - EIN News
New York State Common Retirement Fund Sells 24,581 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Will IDEXX Laboratories Inc. (IX1) stock extend growth storyQuarterly Portfolio Report & Technical Confirmation Alerts - Newser
If You Invested $1000 in Idexx Laboratories 10 Years Ago, This Is How Much You'd Have Now - sharewise.com
Idexx Labs Poised to Benefit From Adoption of InVue Cellular Analyzer - Morningstar
Railway Pension Investments Ltd Sells 10,800 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Mackenzie Financial Corp - MarketBeat
Schroder Investment Management Group Has $169.37 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Purchased by Skandinaviska Enskilda Banken AB publ - MarketBeat
Steward Partners Investment Advisory LLC Has $2.07 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Grandeur Peak Global Advisors LLC Has $2.59 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Capital Counsel LLC NY Sells 6,239 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Capital Fund Management S.A. Sells 8,714 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Bought by Choreo LLC - MarketBeat
Boston Family Office LLC Trims Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Advisors Asset Management Inc. Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Tsai Capital Corp - MarketBeat
WealthTrust Axiom LLC Invests $219,000 in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):